InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (8 ops.)
Insider track record
OtherDisclosed buys
2
Disclosed sells
8
T+90 hit rate
0%
T+90 mean return
-25.6%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by A2A Pharmaceuticals, Inc.. Officer active across 1 company, notably Biomea Fusion, Inc.. Aggregated, 10 filings have been logged. Split: 2 buys · 8 sells. Total volume traded: €24.5m. History available since 17 September 2021. The latest transaction was filed on 31 May 2023 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to A2A Pharmaceuticals, Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
75,000 shares@ US$33.819.5% of flowCommon StockSEC:0001859061-23-000007:0
25,000 shares@ US$33.843.1% of flowCommon StockSEC:0001859061-23-000006:0
100,000 shares@ US$33.993112.4% of flowCommon StockSEC:0001859061-23-000005:0
200,000 shares@ US$29.118821.4% of flowCommon StockSEC:0001859061-23-000004:0
200,000 shares@ US$31.2523.1% of flowCommon StockSEC:0001859061-23-000002:0
200,000 shares@ US$31.2523.1% of flowCommon StockSEC:0001859061-23-000003:0
30,684 shares@ US$13.8721.7% of flowCommon StockSEC:0001859061-22-000002:0
Canonical exit: 14 Nov 2022 (T+90)
34,658 shares@ US$11.211.5% of flowCommon StockSEC:0001859061-22-000001:0
34,658 shares@ US$11.760.40% mcap37.5% of flowCommon StockSEC:0001856641-22-000001:0
34,658 shares@ US$10.961.7% of flowCommon StockSEC:0000899243-21-036769:0
Canonical exit: 16 Dec 2021 (T+90)
10 of 10 declarations
About A2A Pharmaceuticals, Inc.
A2A Pharmaceuticals, Inc. is a declarant linked to Biomea Fusion, Inc. (XNAS). The record shows 10 filings in total, and across the 10 sampled filings, buys amount to EUR 741304 and sells to EUR 23776473, with filings ranging from 2021-09-21 to 2023-06-02, and the modal transaction nature being Sale.
